⌘K

Login Start Free

Home/Filings/4/0001127602-20-009825

4//SEC Filing

Avruch Steven 4

Accession 0001127602-20-009825

CIK 0001681087other

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:23 PM ET

Size

5.2 KB

Accession

0001127602-20-009825

Insider Transaction Report

Form 4

Period: 2020-03-04

AVROBIO, Inc.AVRO

VP & General Counsel

Transactions

Award
Stock Option (Right to Buy)
2020-03-04+90,000→ 90,000 total
Exercise: $21.44Exp: 2030-03-03→ Common Stock (90,000 underlying)

Footnotes (1)

[F1]25% of the shares shall vest and become exercisable on February 3, 2021, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

AVROBIO, Inc.

CIK 0001681087

Entity typeother

Related Parties

1

filerCIK 0001762236

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 4:23 PM ET
Size: 5.2 KB

View on SEC.gov